Q&A: Shift Technology co-founder and chief scientific officer Eric Sibony on the future of automation and ‘autonomy’ in claims handling

Eric Sibony Shift

Claims automation has been described as the Holy Grail of insurance as it can provide a clear point of differentiation in a competitive market, while delivering significant efficiency savings for insurers. Insurance Post spoke to Eric Sibony, co-founder and chief scientific officer at Shift Technology, about the possibilities that AI opens in terms of automation or ‘autonomy’ in claims handling, including ‘first time resolution’.

What would you describe as ‘true’ claims automation? And how does it marry up with buzz words that are increasingly bandied about like ‘low / no touch claims’ and ‘straight through processing’?

True

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Spotlight: Insurance Fraud

Insurance Post’s 2024 Fraud survey found that opportunistic claims fraud, organised claims fraud, application fraud and identity fraud have all risen in the past 12 months.

Hot works – how not to get burned

Risk improvement can boost an insurer’s bottom line and help customers avoid damaging and disruptive incidents. However, RiskSTOP’s Lisa Beaton finds underwriters’ risk requirements are not always valued, and that one intervention presents a particular challenge

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here